Abstract：
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. It is estimated that 65,950 new uterine cancer cases will have occurred in 2022, with 12,550 deaths resulting from the disease. Endometrial carcinoma includes pure endometrioid cancer and carcinomas with high-risk endometrial histology (including uterine serous carcinoma, clear cell carcinoma, carcinosarcoma [also known as malignant mixed Müllerian tumor], and undifferentiated/dedifferentiated carcinoma). Stromal or mesenchymal sarcomas are uncommon subtypes accounting for approximately 3% of all uterine cancers. This selection from the NCCN Guidelines for Uterine Neoplasms focuses on the diagnosis, staging, and management of pure endometrioid carcinoma. The complete version of the NCCN Guidelines for Uterine Neoplasms is available online at NCCN.org.
摘要：
子宫内膜腺癌（也称为子宫内膜癌，或更广泛地说，子宫癌或子宫体癌）是美国女性生殖道最常见的恶性肿瘤。据估计，2022年将发生65,950例新的子宫癌病例，导致12,550例死亡。子宫内膜癌包括纯子宫内膜样癌和具有高危子宫内膜组织学的癌（包括子宫浆液性癌，透明细胞癌,癌肉瘤[也称为恶性混合苗勒管肿瘤]，和未分化/去分化癌)。基质或间质肉瘤是不常见的亚型，约占所有子宫癌的3％。从NCCN子宫肿瘤指南中选择的重点是诊断，分期,和纯子宫内膜样癌的治疗。NCCN子宫肿瘤指南的完整版本可在NCCN.org在线获得。
